Piramal Pharma

175.95

+7.66

(4.55%)

Market Cap

23,425.07 Cr

PE Ratio

-68.65

Volume

3,34,16,572.00

Day High - Low

179.25 - 168.10

52W High-Low

220.85 - 132.30

compare with

Sun Pharmaceutical

1,904.80 (+1.81%)

Divis Laboratories

6,757.00 (+1.11%)

Torrent Pharmaceuticals

4,768.30 (+2.29%)

Cipla

1,458.20 (+0.15%)

Zydus Life Science

1,140.60 (+3.71%)

Key Fundamentals

Market Cap

23,425.07 Cr

EPS

-2.46

PE Ratio

-68.65

PB Ratio

2.74

Book Value

61.34

EBITDA

725.48

Dividend Yield

0.00 %

Industry

Healthcare

Sector

Pharmaceuticals

Return on Equity

1.12

Debt to Equity

0.60

Actual

Company News

View All News

Piramal Pharma files BRSR for FY 2025-26

2 days ago

Piramal Pharma Limited filed its Business Responsibility and Sustainability Report for FY 2025-26, disclosing ESG metrics and third-party assurance.

Piramal Pharma FY2026 Annual Report Key Highlights

2 days ago

Piramal Pharma reports ₹8,869 Crore revenue in FY2026, posts net loss of ₹325.94 Crore, acquires Kenalog® for USD 35 million, and schedules 6th AGM for July 30, 2026.

Piramal Pharma declares no encumbrance on shares

5 days ago

Piramal Pharma Limited's promoters have not encumbered any shares during FY 2025-2026, as per SEBI SAST regulations.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,904.80	#1 4,57,025.33	39.02	#1 58,220.10	6.38	#1 11,565	25.80	69.58
Divis Laboratories	6,757.00	1,79,377.12	69.00	10,560.00	8.73	2,520	13.44	55.41
Torrent Pharmaceuticals	4,768.30	1,61,380.94	73.80	13,886.20	20.34	2,138	-26.91	70.39
Cipla	1,458.20	1,17,800.00	30.47	29,044.60	2.24	3,870	-55.32	66.80
Zydus Life Science	1,140.60	1,14,771.05	21.60	26,719.70	13.65	5,242	7.82	66.88
Dr Reddys Laboratories	1,374.10	1,14,691.88	27.03	33,593.30	-0.44	3,998	-86.05	67.04
Lupin	2,476.00	1,13,210.78	#1 20.48	27,487.50	19.98	5,345	#1 87.72	71.73
Mankind Pharma	2,528.60	1,04,430.16	53.00	14,277.60	12.03	1,750	31.75	60.79
Aurobindo Pharma	1,620.50	93,239.99	25.87	33,384.70	3.21	3,376	1.99	70.76
Laurus Labs	1,542.30	83,262.08	92.55	6,867.80	#1 22.01	890	21.18	71.63

Automatic Screeners on ScanX

Day 1 Unusual Volume

Day 5 Unusual Volume

5% Fall from Low

Resistance 1 Breached

Resistance 2 Breached

Resistance 3 Breached

1 Week High Break

2 Week High Break

4 Week High Break

Growth Rate

Revenue Growth

-4.49 %

Net Income Growth

-471.21 %

Cash Flow Change

-11.17 %

ROE

386.96 %

ROCE

22.30 %

EBITDA Margin (Avg.)

-53.32 %

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
30 Jul 2026	Annual General Meeting	NA	30 Jul 2026	168.20	175.95
02 Aug 2023	Rights	5:46	02 Aug 2023	101.95	103.86
12 Jul 2024	Dividend	₹ 0.11 /share	12 Jul 2024	148.05	151.60
26 Jul 2024	Annual General Meeting	NA	26 Jul 2024	157.10	166.30
23 Oct 2024	Quarterly Result Announcement	NA	23 Oct 2024	221.30	215.15
28 Jan 2025	Quarterly Result Announcement	NA	28 Jan 2025	221.25	224.00
14 May 2025	Quarterly Result Announcement	NA	14 May 2025	214.95	214.90
16 Jul 2025	Dividend	₹ 0.14 /share	16 Jul 2025	214.90	216.22
28 Jul 2025	Quarterly Result Announcement	NA	28 Jul 2025	216.88	202.23
30 Jul 2025	Annual General Meeting	NA	30 Jul 2025	199.95	205.61
05 Nov 2025	Quarterly Result Announcement	NA	05 Nov 2025	203.60	200.42
28 Jan 2026	Quarterly Result Announcement	NA	28 Jan 2026	168.10	152.45
28 Apr 2026	Quarterly Result Announcement	NA	28 Apr 2026	147.45	168.78

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
Bajaj Finserv Small Cap Fund Direct-Growth	1.50%	110772	0.13%	0.22%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth	0.53%	2629	0.03%	0.03%
JioBlackRock Sector Rotation Fund Direct-Growth	0.08%	1180	0.01%	0.01%
DSP Nifty Healthcare Index Fund Direct-Growth	1.03%	701	0.04%	0.15%
DSP Nifty Smallcap 250 Index Fund Direct-Growth	0.53%	423	0.02%	0.04%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth	0.26%	283	0.01%	0.26%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth	0.18%	162	0.01%	0.02%
DSP Nifty 500 Index Fund Direct-Growth	0.06%	18	0.01%	0.01%
Motilal Oswal BSE 1000 Index Fund Direct-Growth	0.05%	18	0.00%	0.00%
ICICI Prudential Midcap Direct Plan-Growth	0.24%	0	0.00%	0.01%
HDFC BSE 500 Index Fund Direct-Growth	0.06%	0	0.00%	0.01%
Axis Arbitrage Fund Direct-Growth	0.00%	0	0.00%	0.00%
Axis Nifty 500 Index Fund Direct-Growth	0.06%	0	0.00%	0.00%
Axis Nifty Smallcap 50 Index Fund Direct-Growth	1.44%	0	0.00%	0.06%
Bajaj Finserv Flexi Cap Fund Direct-Growth	1.27%	0	0.00%	0.39%
Bajaj Finserv Healthcare Fund Direct-Growth	6.51%	0	0.00%	0.24%
Bajaj Finserv Large and Mid Cap Fund Direct-Growth	0.95%	0	0.00%	0.10%
Bandhan Arbitrage Fund Direct-Growth	0.00%	0	0.00%	0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth	0.72%	0	0.00%	0.01%
Bandhan Nifty Alpha 50 Index Fund Direct-Growth	0.00%	0	0.00%	0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth	0.53%	0	0.00%	0.03%
Bandhan Nifty Total Market Index Fund Direct-Growth	0.05%	0	0.00%	0.00%
Bandhan Small Cap Fund Direct-Growth	0.63%	0	0.00%	0.00%
Baroda BNP Paribas Arbitrage Fund Direct-Growth	0.00%	0	0.00%	0.00%
Canara Robeco Balanced Advantage Fund Direct-Growth	0.00%	0	0.00%	0.00%

Technical Indicators

RSI(14)

Neutral

61.20

ATR(14)

Volatile

6.46

STOCH(9,6)

Neutral

59.84

STOCH RSI(14)

Overbought

81.29

MACD(12,26)

Bullish

0.99

ADX(14)

Weak Trend

21.64

UO(9)

Bearish

43.56

ROC(12)

Uptrend And Accelerating

7.50

WillR(14)

Overbought

-15.60

About Piramal Pharma

Piramal Pharma Limited is an Indian pharmaceutical company incorporated in 2020. It offers a diverse portfolio of products and services through 17 global facilities and distribution in over 100 countries. The company operates through three main segments: an integrated Contract Development and Manufacturing Organization (CDMO) business, a Complex Hospital Generics...more

Website

https://www.piramalpharma.com

Chairperson NameNandini Piramal

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104